Baptist Health Cancer Care to Present Research on Precision Radiation Therapy Across Complex Cancers at ASTRO 2026 - Report - MDSpire
Advertisement
Baptist Health Cancer Care to Present Research on Precision Radiation Therapy Across Complex Cancers at ASTRO 2026
Experts across Baptist Health Herbert Wertheim Cancer Institute and Eugene M. & Christine E. Lynn Cancer Institute will present new radiation oncology research and clinical expertise at the 2026 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 26-30, 2026, in Boston.
Clinical Report: Baptist Health Cancer Care to Present Research on Precision Radiation Therapy
Overview
Baptist Health Cancer Care will present research on precision radiation therapy at ASTRO 2026, focusing on complex cancers. Key topics include MR-guided adaptive radiation therapy, radiopharmaceutical therapy, and proton therapy.
Background
The advancement of precision radiation therapy is important in cancer treatment. The upcoming presentations at ASTRO 2026 will showcase research that reflects these advancements.
Data Highlights
No specific numerical data was provided in the source material.
Key Findings
Research includes analyses of PSMA PET-derived biomarkers in metastatic castration-resistant prostate cancer.
Early intracranial radiotherapy is associated with improved survival in breast cancer brain metastases.
Ablative MR-guided adaptive radiotherapy is being evaluated for anatomically challenging tumors.
Outcomes following proton craniospinal irradiation for solid tumor leptomeningeal metastasis are being investigated.
Four oral and 17 poster presentations will be made by Herbert Wertheim Cancer Institute researchers.
Clinical Implications
The findings presented at ASTRO 2026 may inform clinical practices in radiation oncology, particularly in the management of complex cancers. The focus on precision therapies highlights the need for ongoing research to optimize treatment strategies.
Conclusion
The presentations at ASTRO 2026 will contribute to the ongoing dialogue in radiation oncology, emphasizing the importance of innovative approaches in treating complex cancers.
